Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.56K Hold
274
﹤0.01% 1934
2026
Q1
$4.01K Buy
274
+69
+34% +$1.01K ﹤0.01% 2025
2025
Q4
$2.59K Buy
205
+114
+125% +$1.68K ﹤0.01% 2107
2025
Q3
$1.4K Buy
91
+11
+14% +$177 ﹤0.01% 2236
2025
Q2
$1.26K Buy
+80
New +$1.21K ﹤0.01% 2211
2024
Q4
Sell
-640
Closed -$16.7K 2887
2024
Q3
$16.7K Buy
640
+446
+230% +$12.6K ﹤0.01% 2016
2024
Q2
$4.24K Buy
+194
New +$4.04K ﹤0.01% 2253
2024
Q1
Sell
-56
Closed -$1K 2632
2023
Q4
$1K Buy
56
+39
+229% +$785 ﹤0.01% 2401
2023
Q3
$0 Sell
17
-3
-15% -$59 ﹤0.01% 2256
2023
Q2
$0 Sell
20
-54
-73% -$1.09K ﹤0.01% 2452
2023
Q1
$1K Buy
+74
New +$1.42K ﹤0.01% 2203

Other funds holding RXO

Blue Trust Inc's RXO Position: Q2 2026 in Review

Blue Trust Inc held its RXO (RXO) position steady in Q2 2026 at 274 shares worth $7.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Blue Trust Inc first reported a position in RXO in Q1 2023 and has held it in 11 quarters since. The position peaked at $16.7K in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Blue Trust Inc held 274 shares of RXO worth $7.56K as of Q2 2026.
  • Blue Trust Inc left its RXO share count unchanged in Q2 2026.
  • RXO made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1934 holding.
  • Blue Trust Inc first reported a position in RXO in Q1 2023 and has held it in 11 quarters since.
  • Blue Trust Inc's RXO position peaked at $16.7K in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.